SPHINGOLIPID METABOLISM AS A TARGET FOR THE CHEMOTHERAPY ENHANCEMENT IN SORAFENIB AND CISPLATIN TREATMENT
Our research is devoted to the study of the molecular mechanisms of cell death and proliferation, as they are involved in the development of different human pathologies.